Abrysvo lyophilized antigen for injection Images
Generic Name: rsv vaccine, pref a-pref b, recombinant
This medication has been identified as Abrysvo lyophilized antigen for injection. It is supplied by Pfizer Inc.
Abrysvo is used in the treatment of RSV Vaccination and Immunization; RSV and belongs to the drug class viral vaccines. Abrysvo lyophilized antigen for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Abrysvo
- Generic Name
- rsv vaccine, pref a-pref b, recombinant
- Strength
- lyophilized antigen for injection
- Availability
- Prescription only
- Drug Class
- Viral vaccines
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0344
More about Abrysvo (rsv vaccine, pref a-pref b, recombinant)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.